Skip to content
Screener

Perspective Therapeutics CATX Operating Lease ROU Assets

Operating Lease ROU Assets at other companies

CytomX Therapeutics logo
CytomX TherapeuticsCTMX
$5.04M-15.3%
Immunome logo
ImmunomeIMNM
$3.94M+20.6%
uniQure logo
uniQureQURE
$11.61M-14.9%
Tango Therapeutics logo
Tango TherapeuticsTNGX
$34.65M-12.7%
Monopar Therapeutics logo
Monopar TherapeuticsMNPR
$239.88K+2,535%
Varex Imaging Corporation logo
Varex Imaging CorporationVREX
$27.7M+14.9%

Other financials

Income statement

See full
Revenue$2.2M+27.3%
Gross profit$738.0K+78.3%
Operating income-$29.3M-21.7%
Net income-$26.8M-24.7%
EPS (diluted)-$0.22+24.1%

Balance sheet

See full
Cash & equivalents$48.5M+68.1%
Total debt$3.9M+11.1%
Total equity$323.9M+21.9%
Total assets$392.0M+26.2%

Cash flow

See full
Operating cash flow-$20.7M-3.5%
CapEx$14.2M+1,284%
Free cash flow-$34.8M-66.1%

Valuation

See full
Market cap$342.14M+25.3%
Enterprise value$297.56M+20.1%

Profitability

See full
Gross margin33.1%-7.1pp
Operating margin-292.7%-553pp
Net margin-218.4%-781pp

Returns & leverage

See full
Return on equity-39.5%+14.0pp
Debt / equity0.0×
Current ratio6.6×-8.5×

Where this comes from

Reported directly by Perspective Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.

The source filing: Perspective Therapeutics’s 10-Q, filed August 10, 2026.

Filed
Aug 10, 2026, 4:34 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-342512
Line itemJune 30, 2026December 31, 2025
Total current assets241,523148,389
Noncurrent assets:
Property and equipment, net107,79776,597
Right-of-use asset2,1961,500
Intangible assets, in-process research and development40,00040,000
Other assets509486
Total assets$392,025$266,972
LIABILITIES AND STOCKHOLDERSʼ EQUITY

ITEM 1 - FINANCIAL STATEMENTS

FAQ

What is Perspective Therapeutics's operating lease ROU assets?
Perspective Therapeutics (CATX) reported operating lease ROU assets of $2.2M in Q2 2026.
How has Perspective Therapeutics's operating lease ROU assets changed year-over-year?
Perspective Therapeutics's operating lease ROU assets increased by 24.3% year-over-year, from $1.77M to $2.2M.
What is the long-term trend for Perspective Therapeutics's operating lease ROU assets?
Over 5 years (2020 to 2025), Perspective Therapeutics's operating lease ROU assets has grown at a 11.0% compound annual growth rate (CAGR), from $891K to $1.5M.
What does operating lease ROU assets mean?
Right-of-use assets representing the lessee's right to use leased property over the lease term under ASC 842 operating lease classification.

Ask your AI about Perspective Therapeutics's operating lease rou assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude